Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Tina S. Wu"'
Autor:
Joanne Rispoli, Eric Fixsen, Soterios Gyftopoulos, Tina S Wu, Leon Rybak, Michael P. Recht, Catherine Jamin
Publikováno v:
Journal of the American College of Radiology. 16:327-332
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3234d18fd4fbe552e0e372fb9e805ab
https://doi.org/10.1016/j.jacr.2018.11.003
https://doi.org/10.1016/j.jacr.2018.11.003
Autor:
Chiew Loon Koo, Alexandra Ruan, Yeu Sheng Tyan, Chih Ping Han, Ya Wen Cheng, Lai Fong Kok, Po Hui Wang, Ming-Yung Lee, Tina S. Wu
Publikováno v:
Archives of Gynecology and Obstetrics. 281:317-323
The choice of appropriate therapeutic plans for primary endocervical adenocarcinomas (ECA) and endometrial adenocarcinomas (EMA) depends on the tumor's site of origin. Some panels of antibodies help to distinguish primary ECA from EMA. However, unexp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60572df40069e5cfb5f64e1c86e5fdb0
https://doi.org/10.1007/s00404-009-1115-z
https://doi.org/10.1007/s00404-009-1115-z
Autor:
Ming-Yung Lee, Mei Fen Kung, Yeu Sheng Tyan, Lai Fong Kok, Chih Ping Han, Tina S. Wu, Ya Wen Cheng, Po Hui Wang
Publikováno v:
Archives of Gynecology and Obstetrics. 281:293-300
Endocervical adenocarcinomas (ECAs) and endometrial adenocarcinomas (EMAs) are malignancies that affect the uterus; however, their biological behaviors are quite different. This distinction has clinical significance because the appropriate therapy ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fab88991acfbec1ffbc1505f054e5c81
https://doi.org/10.1007/s00404-009-1094-0
https://doi.org/10.1007/s00404-009-1094-0
Publikováno v:
Pharmacotherapy. 22:123-125
Hypertriglyceridemia is a well-recognized complication of protease inhibitor therapy, specifically ritonavir. Fibrate derivatives are recommended as first-line therapy for isolated triglyceride elevations, and gemfibrozil has been successful for mana
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c908086f51d7fc83b330ecb9e9ee2ae
https://doi.org/10.1592/phco.22.1.123.33501
https://doi.org/10.1592/phco.22.1.123.33501
Autor:
Yeu Sheng Tyan, Tina S. Wu, Ya Wen Cheng, Alexandra Ruan, Chih Ping Han, Ching Yi Lin, Ming Yung Lee, Lai Fong Kok
Publikováno v:
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists. 28(5)
Endocervical adenocarcinomas (ECAs) and endometrial adenocarcinomas (EMAs) are malignancies that affect the uterus; however, their biologic behaviors are quite different. This distinction has clinical significance, because the appropriate therapy may
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::965b997c1c441f8f4515a57142d886ca
https://pubmed.ncbi.nlm.nih.gov/19696622
https://pubmed.ncbi.nlm.nih.gov/19696622
Autor:
Chiung-Ling Liao, Po-Hui Wang, Chiew-Loon Koo, Yeu-Sheng Tyan, Chih-Ping Han, Ming-Yung Lee, Tina S. Wu, Kuan-Chong Chao, Lai-Fong Kok
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, Vol 7, Iss 1, p 37 (2009)
Journal of Translational Medicine, Vol 7, Iss 1, p 37 (2009)
Objective Endocervical adenocarcinomas (ECA) and endometrial adenocarcinomas (EMA) are uterine malignancies that have differing biological behaviors. The choice of an appropriate therapeutic plan rests on the tumor's site of origin. In this study, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5af742045b8a63d10bbcfd39894c32b2
https://doi.org/10.1186/1479-5876-7-37
https://doi.org/10.1186/1479-5876-7-37
Autor:
Lai Fong Kok, Ming-Yung Lee, Chih Ping Han, Shun-Fa Yang, Tina S. Wu, Po Hui Wang, Yeu Sheng Tyan, Ya Wen Cheng
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 22(6)
Endocervical adenocarcinomas and endometrial adenocarcinomas are malignancies that affect uterus; however, their biological behaviors are quite different. This distinction has clinical significance, because the appropriate therapy may depend on the s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf65097a6ec7fbe641763422c4ae7a38
https://pubmed.ncbi.nlm.nih.gov/19347018
https://pubmed.ncbi.nlm.nih.gov/19347018
Autor:
Ming-Yung Lee, Chia Herng Yue, Chih Ping Han, Yeu Sheng Tyan, Tina S. Wu, Po Hui Wang, Lai Fong Kok, Ya Wen Cheng
Publikováno v:
Archives of gynecology and obstetrics. 281(5)
The choice of appropriate therapeutic plans for primary endocervical adenocarcinomas (ECA) and endometrial adenocarcinomas (EMA) depend on the tumor's site of origin. The purpose of this study was to compare the performances of the commonly used thre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::feb17072dc97ae8fa8f9238f61300112
https://pubmed.ncbi.nlm.nih.gov/19847454
https://pubmed.ncbi.nlm.nih.gov/19847454
Autor:
Ya Wen Cheng, Ming-Yung Lee, Yeu Sheng Tyan, Mei Fen Kung, Chih Ping Han, Tina S. Wu, Po Hui Wang, Chung Chin Yao, Lai Fong Kok
Publikováno v:
Archives of gynecology and obstetrics. 280(3)
Endocervical adenocarcinomas (ECA) and endometrial adenocarcinomas (EMA) are uterine malignancies that have differing biological behavior. The choice of appropriate therapeutic plan depends indeed on the tumor’s site of origin. In this study, we no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c14d58781fc981ea704a0a8179c16f14
https://pubmed.ncbi.nlm.nih.gov/19153755
https://pubmed.ncbi.nlm.nih.gov/19153755
Autor:
Chiew-Loon Koo, Lai-Fong Kok, Ming-Yung Lee, Tina S. Wu, Ya-Wen Cheng, Jeng-Dong Hsu, Alexandra Ruan, Kuan-Chong Chao, Chih-Ping Han
Publikováno v:
Journal of Translational Medicine; 2009, Vol. 7, p1-10, 10p, 2 Color Photographs, 1 Diagram, 2 Charts